Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus (DM) is characterized by insulin resistance and pancreatic β cell dysfunction. In high-risk subjects, the earliest detectable abnormality is insulin resistance in skeletal muscle. Impaired insulin-mediated signaling, gene expression, glycogen synthesis, and accumulation of intramyocellular triglycerides have all been linked with insulin resistance, but no specific defect responsible for insulin resistance and DM has been identified in humans. To identify genes potentially important in the pathogenesis of DM, we analyzed gene expression in skeletal muscle from healthy metabolically characterized nondiabetic (family history negative and positive for DM) and diabetic Mexican–American subjects. We demonstrate that insulin resistance and DM associate with reduced expression of multiple nuclear respiratory factor-1 ( NRF-1 )-dependent genes encoding key enzymes in oxidative metabolism and mitochondrial function. Although NRF-1 expression is decreased only in diabetic subjects, expression of both PPARγ coactivator 1-α and-β ( PGC1- α/ PPARGC1 and PGC1- β/ PERC ), coactivators of NRF-1 and PPAR γ-dependent transcription, is decreased in both diabetic subjects and family history-positive nondiabetic subjects. Decreased PGC1 expression may be responsible for decreased expression of NRF-dependent genes, leading to the metabolic disturbances characteristic of insulin resistance and DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, two groups independently showed that NGT offspring of two type 2 diabetic parents had a reduced expression of key mitochondrial genes involved in the regulation of oxidative metabolism in skeletal muscle ( 63 , 64 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is based on the finding that type 2 diabetics and insulin-resistant individuals with impaired glucose tolerance have ≈30% less mitochondria in their muscles than insulin-sensitive control subjects (3–7).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nonetheless, investigators found that insulin sensitivity correlated positively with skeletal muscle oxidative potential, assessed by enzyme activities as well as genome-wide expression arrays (Patti et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Patti et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A down-regulation of genes involving mitochondrial enzymes declines mitochondrial content, which has been found in insulin resistant states (39, 40), augmenting accumulation of fat in muscle and liver.”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, not only PGC 1α upregulation is paralleled by an improvement in insulin sensitivity, but also PGC 1α-dependent defects in mitochondrial oxidative metabolism are reversible confirming this transcription cofactor as a valuable target to restore insulin sensitivity and the aberrant transcriptional control of mitochondrial biogenesis (Mootha et al., 2003; Patti et al., 2003).”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Patti et al., 2003
Experimental — accuracy not yet measured
28 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Numerical recipes in Pascal: the art of scientific computing
(1990) · Choice Reviews Online · doi:10.5860/choice.27-5158 · Cited by 11,811
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Self-citationNumerical Recipes in C: The Art of Scientific Computing.
Birchenhall, C., Press, W. H., Teukolsky, S. A., Vetterling, W. T., & Flannery, B. P. (1994) · The Economic Journal · doi:10.2307/2234664 · Cited by 4,355
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Research works printed but not linked: 3
- Schadt, E. E., Li, C., Su, C. & Wong, W. H. (2000) J. Cell Biochem. 80, 192-202.11074587
- Dudait, S., Yang, Y. H. & Speed, T. P. (2002) Stat. Sin. 12, 111-139.
- Mootha V. Lindgren C. Eriksson K. Subramian A. Sihaq S. Lehar J. Puigserver P. Carlsson E. Ridderstrale M. Laurila E. et al . (2003) Nat. Genet. in press.
Cited by
Items 301–400 of 1,014
Eckardt, K., Taube, A., & Eckel, J. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9168-2 · Cited by 181
Redox regulation of mitochondrial biogenesis
Piantadosi, C. A., & Suliman, H. B. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.014 · Cited by 177
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
Audet-walsh, É., & Giguére, V. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.121 · Cited by 176
Skeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle.
Rönn, T., Poulsen, P., Hansson, O., Holmkvist, J., Almgren, P., Nilsson, P., Tuomi, T., Isomaa, B., Groop, L., Vaag, A., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1018-8 · Cited by 175
“PGC-1α (also known as PPARGC1A) and PGC-1β (also known as PPARGC1B), in skeletal muscle from patients with type 2 diabetes [2–5].”
BackgroundGershman, B., Puig, O., Hang, L., Peitzsch, R. M., Tatar, M., & Garofalo, R. S. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00061.2006 · Cited by 175
Lefort, N., Glancy, B., Bowen, B., Willis, W. T., Bailowitz, Z., De Filippis, E. A., Brophy, C., Meyer, C., Højlund, K., Yi, Z., et al. (2010) · Diabetes · doi:10.2337/db10-0174 · Cited by 174
“Reduced Cpt1B protein level could be a direct consequence of lower PGC-1 gene expression reported in insulin-resistant muscle (44,45).”
BackgroundSelf-citationMitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1β
Liesa, M., Borda-d'Água, B., Medina-Gómez, G., Lelliott, C. J., Paz, J. C., Rojo, M., Palacín, M., Vidal-Puig, A., & Zorzano, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003613 · Cited by 174
Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals
Holloway, G. P., Bonen, A., & Spriet, L. L. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717b · Cited by 175
Laustsen, P. G., Russell, S. J., Cui, L., Entingh-Pearsall, A., Holzenberger, M., Liao, R., & Kahn, C. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01110-06 · Cited by 173
“Consistent with this finding, electron transport and mitochondrial fatty acid beta-oxidation genes are down-regulated in the skeletal muscles of patients with diabetes mellitus (DM) or those with a family history of DM (33, 37).”
BackgroundResultInfluentialSelf-citationInsulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 176
Self-citationIncreased collagen content in insulin-resistant skeletal muscle
Berria, R., Wang, L., Richardson, D. K., Finlayson, J., Belfort, R., Pratipanawatr, T., De Filippis, E. A., Kashyap, S., & Mandarino, L. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00202.2005 · Cited by 171
Self-citationIncreased DNA methylation variability in type 1 diabetes across three immune effector cell types
Paul, D. S., Teschendorff, A. E., Dang, M. A. N., Lowe, R., Hawa, M. I., Ecker, S., Beyan, H., Cunningham, S., Fouts, A. R., Ramelius, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13555 · Cited by 171
PGC-1β-Regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERRα
Shao, D., Liu, Y., Liu, X., Zhu, L., Cui, Y., Cui, A., Qiao, A., Kong, X., Liu, Y. U., Chen, Q., et al. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.012 · Cited by 172
He, F., Huang, Y., Song, Z. Q., Zhou, H. J., Zhang, H., Perry, R. J., Shulman, G. I., & Wang, M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201416 · Cited by 171
The Role of Reactive Oxygen Species in the Life Cycle of the Mitochondrion
Venditti, P., & Di Meo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062173 · Cited by 170
Yan, W., Zhang, H., Liu, P., Wang, H., Liu, J., Gao, C., Liu, Y., Lian, K., Yang, L., Sun, L., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0329-1 · Cited by 169
‘Metabolically healthy obesity’: Origins and implications
Denis, G. V., & Obin, M. S. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.004 · Cited by 169
Li, S., Liu, C., Li, N., Hao, T., Han, T., Hill, D. E., Vidal, M., & Lin, J. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.013 · Cited by 169
Sirtuin 1-mediated Effects of Exercise and Resveratrol on Mitochondrial Biogenesis
Menzies, K. J., Singh, K., Saleem, A., & Hood, D. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431155 · Cited by 167
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 154
The role of aberrant mitochondrial bioenergetics in diabetic neuropathy
Chowdhury, S. K. R., Smith, D. R., & Fernyhough, P. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.016 · Cited by 166
Tiffin, N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl381 · Cited by 145
Self-citationDorenkott, M. R., Griffin, L. E., Goodrich, K. M., Thompson‐Witrick, K. A., Fundaro, G., Ye, L., Stevens, J. R., Ali, M. M., O’Keefe, S. F., Hulver, M. W., et al. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500333y · Cited by 166
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 166
Ukropcova, B., Sereda, O., de Jonge, L., Bogacka, I., Nguyen, T., Xie, H., Bray, G. A., & Smith, S. R. (2007) · Diabetes · doi:10.2337/db06-0521 · Cited by 165
Hokayem, M., Blond, E., Vidal, H., Lambert, K., Meugnier, E., Feillet-Coudray, C., Coudray, C., Pesenti, S., Luyton, C., Lambert-Porcheron, S., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1652 · Cited by 165
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Colak, Y., Ozturk, O., Senates, E., Tuncer, I., Yorulmaz, E., Adali, G., Doganay, L., & Enc, F. Y. (2011) · Medical Science Monitor · doi:10.12659/msm.881749 · Cited by 165
Jiménez-Flores, L. M., López-Briones, S., Macías-Cervantes, M. H., Ramírez-Emiliano, J., & Pérez‐Vázquez, V. (2014) · Molecules · doi:10.3390/molecules19068289 · Cited by 165
Thyroid hormone-related regulation of gene expression in human fatty liver.
Pihlajamäki, J., Boes, T., Kim, E.-Y., Dearie, F., Kim, B. W., Schroeder, J., Mun, E., Nasser, I., Park, P. J., Bianco, A. C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0212 · Cited by 164
Self-citationMitochondrial Dysfunction in Diabetic Neuropathy: a Series of Unfortunate Metabolic Events
Fernyhough, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0671-9 · Cited by 164
Is mitochondrial dysfunction a cause of insulin resistance?
Turner, N., & Heilbronn, L. K. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.001 · Cited by 164
Sun, X., & Zemel, M. B. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-26 · Cited by 164
Ray Hamidie, R. D., Yamada, T., Ishizawa, R., Saito, Y., & Masuda, K. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.010 · Cited by 164
Papaetis, G. S., Papakyriakou, P., & Panagiotou, T. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.52350 · Cited by 130
Chomentowski, P., Coen, P. M., Radiková, Z., Goodpaster, B. H., & Toledo, F. G. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0822 · Cited by 163
Impaired mitochondrial function in human placenta with increased maternal adiposity
Mele, J., Muralimanoharan, S., Maloyan, A., & Myatt, L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00025.2014 · Cited by 163
Oswal, A., & Yeo, G. (2010) · Obesity · doi:10.1038/oby.2009.228 · Cited by 163
Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome
Lara-Castro, C., & Garvey, W. T. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.09.002 · Cited by 163
Mitochondrial degradation and energy metabolism
Melser, S., Lavie, J., & Bénard, G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.010 · Cited by 163
Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome
Rocha, M., Apostolova, N., Díaz‐Rúa, R., Muntané, J., & Víctor, V. M. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.03.004 · Cited by 163
Mitochondrial biogenesis and the development of diabetic retinopathy
dos Santos, J. M., Tewari, S., Goldberg, A. F. X., & Kowluru, R. A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.017 · Cited by 164
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“Transcriptional analysis reveals that expression of PGC-1α target genes is coordinately down-regulated in human diabetics [84,85] and PGC-1α genetic polymorphisms have been linked to Type II Diabetes [104,105].”
Muscle oxidative capacity during IL-6-dependent cancer cachexia
White, J. P., Baltgalvis, K. A., Puppa, M. J., Sato, S., Baynes, J. W., & Carson, J. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00300.2010 · Cited by 161
Debard, C., Laville, M., Berbe, V., Loizon, E., Guillet, C., Morio, B., Boirie, Y., & Vidal, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1394-7 · Cited by 161
PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
Soyal, S. M., Krempler, F., Oberkofler, H., & Patsch, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0268-6 · Cited by 161
Mensink, M., Hesselink, M. K. C., Russell, A. P., Schaart, G., Sels, J.-P., & Schrauwen, P. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803567 · Cited by 160
Fleischman, A., Johnsen, S., Systrom, D. M., Hrovat, M., Farrar, C. T., Frontera, W., Fitch, K., Thomas, B. J., Torriani, M., Côté, H. C. F., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00550.2006 · Cited by 160
“Evaluation of gene expression in muscle samples from individuals with type 2 DM and impaired glucose tolerance has identified alterations in several genes involved in mitochondrial oxidative phosphorylation (12, 14).”
BackgroundHidalgo, B., Irvin, M. R., Sha, J., Zhi, D., Aslibekyan, S., Absher, D., Tiwari, H. K., Kabagambe, E. K., Ordovas, J. M., & Arnett, D. K. (2014) · Diabetes · doi:10.2337/db13-1100 · Cited by 160
Burgermeister, E., Schnoebelen, A., Flament, A., Benz, J., Stihle, M., Gsell, B., Rufer, A., Ruf, A., Kuhn, B., Märki, H. P., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0171 · Cited by 160
Molecular regulation of mitochondrial dynamics in cardiac disease
Nan, J., Zhu, W. M., Rahman, M. S. U., Liu, M., Li, D. X., Su, S., Zhang, N., Hu, X., Yu, H., Gupta, M. P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.03.006 · Cited by 160
Gomes, A. P., Duarte, F. V., Nunes, P., Hubbard, B. P., Teodoro, J. S., Varela, A. T., Jones, J. G., Sinclair, D. A., Palmeira, C. M., & Rolo, A. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.008 · Cited by 159
“This has been shown in patients with insulin resistance and type 2 diabetes [9–12], as well as in several animal models [13,14].”
BackgroundChanges in adipose tissue gene expression with energy-restricted diets in obese women1–4,
Dahlman, I., Linder, K., Arvidsson Nordström, E., Andersson, I., Lidén, J., Verdich, C., Sørensen, T. I., & Arner, P. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1275 · Cited by 159
Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia
Konradi, C., Westin, J. E., Carta, M., Eaton, M. E., Kuter, K., Dekundy, A., Lundblad, M., & Cenci, M. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.005 · Cited by 159
Li, L., Pan, R., Li, R., Niemann, B., Aurich, A.-C., Chen, Y., & Rohrbach, S. (2011) · Diabetes · doi:10.2337/db10-0331 · Cited by 158
Sachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 158
Timmons, J. A., Larsson, O., Jansson, E., Fischer, H., Gustafsson, T., Greenhaff, P. L., Ridden, J., Rachman, J., Peyrard-Janvid, M., Wahlestedt, C., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-1980com · Cited by 158
Gene Set Enrichment Analysis (GSEA) for Interpreting Gene Expression Profiles
Shi, J., & Walker, M. (2007) · Current Bioinformatics · doi:10.2174/157489307780618231 · Cited by 141
Nitric oxide and mitochondrial biogenesis: A key to long-term regulation of cellular metabolism
Clementi, E., & Nisoli, E. (2005) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpb.2005.04.022 · Cited by 158
De Filippis, E., Alvarez, G., Berria, R., Cusi, K., Everman, S., Meyer, C., & Mandarino, L. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00729.2007 · Cited by 138
Self-citationGenetic dissection of type 2 diabetes
Ridderstråle, M., & Groop, L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.002 · Cited by 155
The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance
Pagel-Langenickel, I., Bao, J., Pang, L., & Sack, M. N. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0003 · Cited by 154
“These are all down-regulated in diabetic subjects compared with normal controls (7).”
BackgroundMethodInfluentialBenton, C. R., Holloway, G. P., Han, X.-X., Yoshida, Y., Snook, L. A., Lally, J., Glatz, J. F. C., Luiken, J. J. F. P., Chabowski, A., & Bonen, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1773-1 · Cited by 154
High-fat diet, muscular lipotoxicity and insulin resistance
Schrauwen, P. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005277 · Cited by 153
“In addition to the down-regulation of the so-called OXPHOS gene set, it has been shown that the expression of PGC-1a itself is also reduced in patients with type 2 diabetes (Mootha et al. 2003; Patti et al. 2003).”
BackgroundTipping the metabolic scales towards increased longevity in mammals
Riera, C. E., & Dillin, A. (2015) · Nature Cell Biology · doi:10.1038/ncb3107 · Cited by 153
Espino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 154
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 152
Coll, T., Jové, M., Rodríguez-Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 151
Mitochondrial biogenesis as a cellular signaling framework
Nisoli, E., Clementi, E., Moncada, S., & Carruba, M. O. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.015 · Cited by 150
Kraunsøe, R., Boushel, R., Hansen, C. N., Schjerling, P., Qvortrup, K., Støckel, M., Mikines, K. J., & Dela, F. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.184754 · Cited by 149
Roden, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803102 · Cited by 149
“28 and that expression of PGC-1 and PGC-1 controlled mitochondrial genes involved in electron transport, oxidative phosphorylation including ATP synthase is impaired in overt T2DM strengthens this hypothesis”
BackgroundShulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 149
Mitochondrial response to nutrient availability and its role in metabolic disease
Gao, A. W., Cantó, C., & Houtkooper, R. H. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303782 · Cited by 148
“Gene-clustering approaches supported the above hypothesis by demonstrating that muscles from T2DM patients display downregulation of lipid oxidation and mitochondrial metabolism genes (Mootha et al , 2003; Patti et al , 2003).”
Mitochondria and PGC-1α in Aging and Age-Associated Diseases
Wenz, T. (2011) · Journal of Aging Research · doi:10.4061/2011/810619 · Cited by 148
Estall, J. L., Kahn, M., Cooper, M. P., Fisher, F. M., Wu, M. K., Laznik, D., Qu, L., Cohen, D. E., Shulman, G. I., & Spiegelman, B. M. (2009) · Diabetes · doi:10.2337/db08-1571 · Cited by 148
Coletta, D. K., Sriwijitkamol, A., Wajcberg, E., Tantiwong, P., Li, M., Prentki, M., Madiraju, M., Jenkinson, C. P., Cersosimo, E., Musi, N., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1256-9 · Cited by 148
Self-citationOliveira, A. P., Patil, K. R., & Nielsen, J. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-17 · Cited by 136
Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus
Abdul-Ghani, M. A., & DeFronzo, R. A. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0030-1 · Cited by 146
Self-citationMeng, Z.-X., Li, S., Wang, L., Ko, H. J., Lee, Y., Jung, D. Y., Okutsu, M., Yan, Z., Kim, J. K., & Lin, J. D. (2013) · Nature Medicine · doi:10.1038/nm.3144 · Cited by 146
Meng, Q., Qi, X., Fu, Y., Chen, Q., Cheng, P., Yu, X., Sun, X., Wu, J., Li, W., Zhang, Q., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112326 · Cited by 145
Akude, E., Zherebitskaya, E., Chowdhury, S. K. R., Smith, D. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Diabetes · doi:10.2337/db10-0818 · Cited by 145
Chandrasekaran, K., Anjaneyulu, M., Choi, J., Kumar, P., Salimian, M., Ho, C.-Y., & Russell, J. W. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.04.002 · Cited by 145
Role of Lipotoxicity in Endothelial Dysfunction
Kim, J.-A., Montagnani, M., Chandrasekran, S., & Quon, M. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.012 · Cited by 144
Watt, M. J., Southgate, R. J., Holmes, A. G., & Febbraio, M. A. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01499 · Cited by 144
Chowdhury, S. K. R., Zherebitskaya, E., Smith, D. R., Akude, E., Chattopadhyay, S., Jolivalt, C. G., Calcutt, N. A., & Fernyhough, P. (2010) · Diabetes · doi:10.2337/db09-1299 · Cited by 144
Xu, Y. X., Nie, L., Yin, Y., Tang, J.-L., Zhou, J., Li, D., & Zhou, S.-W. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.09.028 · Cited by 144
Excess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle
TUMOVA, J., ANDEL, M., & TRNKA, J. (2016) · Physiological Research · doi:10.33549/physiolres.932993 · Cited by 143
“…chain (ETC) (Ritov et al. 2010), decreased expression of genes involved in oxidative metabolism and mitochondrial biogenesis (Mootha et al. 2003, Patti et al. 2003), decreased fat oxidation (Kim et al. 2000) or less abundant mitochondria with a changed morphology (Kelley et al. 2002, Ritov et…”
BackgroundBastin, J., Aubey, F., Rötig, A., Munnich, A., & Djouadi, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1701 · Cited by 142
Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance
Wredenberg, A., Freyer, C., Sandström, M. E., Katz, A., Wibom, R., Westerblad, H., & Larsson, N.-G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.029 · Cited by 141
Katic, M., Kennedy, A. R., Leykin, I., Norris, A., McGettrick, A., Gesta, S., Russell, S. J., Bluher, M., Maratos‐Flier, E., & Kahn, C. R. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00346.x · Cited by 141
Self-citationHyperglycemia decreases mitochondrial function: The regulatory role of mitochondrial biogenesis
Palmeira, C. M., Rolo, A. P., Berthiaume, J. M., Bjork, J. A., & Wallace, K. B. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.07.015 · Cited by 141
Noland, R. C., Thyfault, J. P., Henes, S. T., Whitfield, B. R., Woodlief, T. L., Evans, J. R., Lust, J. A., Britton, S. L., Koch, L. G., Dudek, R. W., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2006 · Cited by 140
Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Crunkhorn, S., & Patti, M.-E. (2008) · Thyroid · doi:10.1089/thy.2007.0249 · Cited by 140
Self-citationRowlands, D. S., Page, R. A., Sukala, W. R., Giri, M., Ghimbovschi, S. D., Hayat, I., Cheema, B. S., Lys, I., Leikis, M., Sheard, P. W., et al. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2014 · Cited by 140
Karnieli, E., & Armoni, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90306.2008 · Cited by 139
Kotani, K., Peroni, O. D., Minokoshi, Y., Boss, O., & Kahn, B. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421341 · Cited by 139
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 143
Structural and Functional Consequences of Mitochondrial Biogenesis in Human Adipocytes in Vitro
Bogacka, I., Ukropcova, B., McNeil, M., Gimble, J. M., & Smith, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1024 · Cited by 138
Metadata
- Authors
- Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., Landaker, E. J., Goldfine, A. B., Mun, E., DeFronzo, R., Finlayson, J., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- Boston Children's Hospital (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-06-27
- Volume
- 100
- Issue
- 14
- Pages
- 8466-8471
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC166252
- OpenAlex
- W2049481764
- Cited by
- 1,952
- References
- 55
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 52 · 2023: 57 · 2022: 50 · 2021: 76 · 2020: 68 · 2019: 62 · 2018: 75 · 2017: 78 · 2016: 100 · 2015: 93 · 2014: 92 · 2013: 92 · 2012: 121
- FWCI
- 29.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association (DK24092)
- Iacocca Family Foundation
- Massachusetts Institute of Technology
- Deutsches Krebsforschungszentrum
- Endocrine Fellows Foundation (DK24092)
- National Institutes of Health (5k08dk002526-03, 5p01hg001323-03, DK24092)
- National Heart, Lung, and Blood Institute (U01HL066582, HL066582)
- National Human Genome Research Institute (P01 HG 01323)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK02526, DK47936, DK063696, R56DK024092, DK 24092, DK06087, R01DK047936, K12DK063696, R01DK060837, U24DK058739, R01DK024092)
- National Center for Research Resources (M01RR001346, RR-01346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- type 2 diabetes, insulin resistance, skeletal muscle, oxidative metabolism, mitochondrial function, NRF1, PGC-1α, PPARγ coactivator, gene expression, family history of diabetes, diabetes pathogenesis
- MeSH terms
- Adult, Biopsy, Citric Acid Cycle, Diabetes Mellitus, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Female, Gene Expression Regulation, Glycolysis, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Oxidative Phosphorylation, Prediabetic State, Transcription Factors, Transcription, Genetic, Lipid Peroxidation, Trans-Activators, Mexican Americans, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Nuclear Respiratory Factors, NF-E2-Related Factor 1, Nuclear Respiratory Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.